Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 2.1 | 2.26 |
NAV | ₹16.16 | ₹165.23 |
Fund Started | 12 May 2023 | 13 Oct 2005 |
Fund Size | ₹1338.82 Cr | ₹1429.17 Cr |
Exit Load | Exit load of 1%, if redeemed within 15 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -9.78% | 7.64% |
3 Year | - | 23.31% |
5 Year | - | 25.90% |
1 Year
3 Year
5 Year
Equity | 96.22% | 90.29% |
Cash | -0.69% | 9.01% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Reliance Industries Ltd. | 9.60% |
JIO Financial Services Ltd. | 6.60% |
HFCL Ltd. | 6.53% |
Samvardhana Motherson International Ltd. | 6.33% |
HDFC Life Insurance Co Ltd. | 6.08% |
DLF Ltd. | 5.62% |
S.P. Apparels Ltd. | 5.14% |
Life Insurance Corporation of India | 5.14% |
Aurobindo Pharma Ltd. | 5.03% |
Alivus Life Sciences Ltd | 3.90% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.99% |
Infosys Ltd. | 7.91% |
Reliance Industries Ltd. | 6.34% |
NTPC Ltd. | 4.77% |
HDFC Bank Ltd. | 4.59% |
Bharti Airtel Ltd. | 3.54% |
Sun Pharmaceutical Industries Ltd. | 3.42% |
State Bank of India | 3.29% |
Larsen & Toubro Ltd. | 3.13% |
Dr. Reddy's Laboratories Ltd. | 3.06% |
Name | Ankit A Pande | Sri Sharma |
Start Date | 11 May 2020 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by investing with focus on riding business cycles through allocation between sectors and stocks at different stages of business cycles. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 12 May 2023 | 13 Oct 2005 |
Description
Launch Date